Phase-II Evaluation of GS-9219 in Canine Cutaneous Lymphoma
Study Details: Phase-II Evaluation of GS-9219 in Canine Cutaneous Lymphoma
Species: Canines
For further information regarding all oncology trials at CSU please complete an online consult request form or call our Oncology Clinical Coordinator at (970) 297-4068.
Study Details: Phase-II Evaluation of GS-9219 in Canine Cutaneous Lymphoma
Species: Canines
Study Details: Monoclonal Antibody Therapy of Canine B-cell Lymphoma
Species: Canines
Study Details: Hydroxychloroquine to Enhance Doxorubicin Effectiveness
Species: Canines
Study Details: PET-CT Imaging of Canine Tumors with 64-Copper-ATSM to Detect Areas of Low Tumor Oxygen Level
Species: Canines
Study Details: Treatment of Mast Cell Tumors with Palladia and CCNU
Species: Canines
Study Details: Palladia vs. Vinblastine in Canine Mast Cell Tumors
Species: Canines
Study Details: Incorporation of PET/CT into Radiation Therapy Planning for Canine Nasal Tumors.
Species: Canines
Study Details: Effect of Carboplatin on Circulating Endothelial Cells in Dogs with Cancer.
Species: Canines